KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Kiniksa Pharmaceuticals International, plc
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$79.48+0.89 (+1.13%)
Close on Oct 19, 2026
- Market cap
- $6.55B
- P/E (TTM)
- 88.3
- Dividend yield
- –
Dividends
Kiniksa Pharmaceuticals International has not reported a dividend
No dividend per share appears in Kiniksa Pharmaceuticals International's annual filings since fiscal 2016.